Long COVID prevalence decreases with vaccine uptake, globally. حسب Manlio De Domenico (626037)

Long COVID prevalence decreases with vaccine uptake in the U.S. حسب Manlio De Domenico (626037)

"…<p>(A) Prevalence in U.S. states and the U.S. exhibits a decreasing trend with respect to vaccine uptake, both in the population vaccinated with at least one dose (top) and two doses (bottom), with the largest gap between 100% vaccinated and 100% unvaccinated scenarios observed in the reference population of adults who had COVID-19. …"

Table 1_Febuxostat may decrease the incidence of COVID-19 infection among patients with gout: a retrospective cohort study.docx حسب Weijie Wang (247184)

Demographic, anthropometric, mobility, health, and cognitive characteristics of the participants (N = 50). حسب Sirinun Boripuntakul (13994171)

Decreased test sensitivity: Screening the whole population. حسب Timo de Wolff (9904467)

Data_Sheet_1_Second Wave of COVID-19 Pandemic in Argentinian Population: Vaccination Is Associated With a Decrease in Depressive Symptoms.pdf حسب Pedro Benedetti (12910259)

Table_1_Risk of psychological distress by decrease in economic activity, gender, and age due to COVID-19: A multinational study.DOCX حسب Minji Kim (1722313)

"…</p>Discussion<p>Psychological distress due to COVID-19 revealed a significant association with decrease in economic activity, women, and younger age. …"

The impact of the COVID-19 pandemic on the decrease in the use of intensive care units in the postoperative period of anatomic lung resections.... حسب ISMAEL RODRIGO DIAS (12990222)

Loss of <i>FGR41</i> or <i>CWP419</i> does not impact susceptibility to cell wall stressors. حسب Andrew S. Wagner (11331477)

E-learning interventions decreased the number of students detected on campus during the COVID-19 outbreak. حسب Sing Chen Yeo (10573857)

"…<p>(<b>A</b>) The timeline of COVID-19 cases and events in Singapore is shown for the second semester of the 2019/20 school year at the National University of Singapore (NUS). …"

Raw FCS data for FC_cd105_adsc4. حسب Parisa Afzal Haghjoo (22453647)

Absence of neocortex is associated with a dorsal shift of piriform cortex in <i>Emx1</i>-cKO mice. حسب Sathish Venkataramanappa (10331993)

The impact of excessive DNA amounts used for bisulfite conversion on the amplification efficiency and the methylation level of <i>LINE-1</i> and <i>Alu</i>. حسب Trang Thi Quynh Tran (20485595)

"…A serial dilution of human methylated DNA amounts, corresponding to 500 ng, 50 ng, 5 ng, 1 ng and 0.5 ng was treated by bisulfite. …"

Crz1 mediates masking in response to exogenous calcium. حسب Andrew S. Wagner (11331477)

<b>Diroximel fumarate acts through Nrf2 to attenuate methylglyoxal-induced nociception in mice and decrease ISR activation in DRG neurons</b> حسب Muhammad Saad Yousuf (20745168)

Plot of mean compassion satisfaction by group and time. حسب Kunal Desai (18784208)

Area of cumulus oocyte complexes (COCs; μm²) at 0, 6, 12 and 19 h of the maturation period. حسب Verónica M. Negrón-Pérez (20691412)

Comparison of the decrease of CFU in CSF and blood between treatment groups within the first 6 h after treatment. حسب Luca G. Valente (12463057)

First-in-Class Hydrazide-Based HDAC6 Selective Inhibitor with Potent Oral Anti-Inflammatory Activity by Attenuating NLRP3 Inflammasome Activation حسب Kairui Yue (11874403)

"…Representative inhibitor <b>35m</b> exhibits potent HDAC6 inhibitory activity with an IC₅₀ value of 0.019 μM. To our surprise, <b>35m</b> establishes significant improvement in the pharmacokinetic property with much higher AUC_0‑inf (10292 ng·h/mL) and oral bioavailability (93.4%) than hydroximic acid-based HDAC6 inhibitors Tubastatin A and ACY-1215. …"

First-in-Class Hydrazide-Based HDAC6 Selective Inhibitor with Potent Oral Anti-Inflammatory Activity by Attenuating NLRP3 Inflammasome Activation حسب Kairui Yue (11874403)

"…Representative inhibitor <b>35m</b> exhibits potent HDAC6 inhibitory activity with an IC₅₀ value of 0.019 μM. To our surprise, <b>35m</b> establishes significant improvement in the pharmacokinetic property with much higher AUC_0‑inf (10292 ng·h/mL) and oral bioavailability (93.4%) than hydroximic acid-based HDAC6 inhibitors Tubastatin A and ACY-1215. …"